These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9763353)

  • 21. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
    Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
    Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
    Lowe GD; Rumley A; Woodward M; Reid E; Rumley J
    Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden mutation in one family of Chinese origin.
    Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
    Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
    Loew A; Jacob D; Neuhaus P; Riess H
    Transplantation; 2005 May; 79(10):1422-7. PubMed ID: 15912114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
    Bossone A; Cappucci F; D'Andrea G; Brancaccio V; Cibelli G; Iannaccone L; Grandone E; Margaglione M
    Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated protein C resistance in anterior ischaemic optic neuropathy.
    Nagy V; Facsko A; Takacs L; Balazs E; Berta A; Balogh I; Edes I; Czuriga I; Pfliegler G
    Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early days of APC resistance and FV Leiden.
    Dahlbäck B
    Hamostaseologie; 2008; 28(3):103-9. PubMed ID: 18521487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology and pathophysiology of APC resistance: current insights and clinical implications.
    Rosing J; Hemker HC; Tans G
    Semin Thromb Hemost; 1998; 24(4):329-35. PubMed ID: 9763350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
    Middeldorp S; Henkens CM; Koopman MM; van Pampus EC; Hamulyák K; van der Meer J; Prins MH; Büller HR
    Ann Intern Med; 1998 Jan; 128(1):15-20. PubMed ID: 9424976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
    Rodeghiero F; Tosetto A
    Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ; Wang P; Fontaine RN; Tracy T; Sieve-Smith L; Lang JE
    Am J Cardiol; 1999 Sep; 84(5):549-54. PubMed ID: 10482153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of factor V Leiden and G6PD 1311 silent mutations in Dalmatian population.
    Cikes V; Abaza I; Krzelj V; Terzić IM; Tafra R; Trlaja A; Marusić E; Terzić J
    Arch Med Res; 2004; 35(6):546-8. PubMed ID: 15631882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.
    Ma DD; Aboud MR; Williams BG; Isbister JP
    Aust N Z J Med; 1995 Apr; 25(2):151-4. PubMed ID: 7605298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension.
    Makris TK; Krespi PG; Hatzizacharias AN; Gialeraki AE; Anastasiadis G; Triposkiadis FK; Mandalaki T; Kyriakidis MK
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):61-5. PubMed ID: 10678272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.